Skip to main navigation
Top Links - Left
BioNTech.com
Newsroom
Investors
Healthcare Professionals
English
Language switcher (Content)
English
German
Top Links - Right
Connect
Main Navigation
BioNTech.com
News
Events & Presentations
Financials
Financials
SEC Filings
Annual Reports
Quarterly Reports
Financial Calendar
Corporate Governance
Corporate Governance
Overview
Transparency
ESG
Stock Info
Stock Info
Stock Quote & Chart
Analyst Coverage
Shareholder Fraud Warning
Share Repurchase Program
Dividend Information
Investor FAQs
Annual General Meeting
Annual General Meeting
Annual General Meeting 2024
Annual General Meeting Archive
Contact Us
Newsroom
Investors
Healthcare Professionals
Breadcrumb
Investors
Search
Search
Filter by content type
(-)
News
(186)
Filter by content year
(-)
2021
(186)
Filter by form group
Filter by category
All
(174)
Collaborators
(126)
Other
(125)
Clinical
(59)
Science
(35)
Events
(18)
Financial
(14)
HR
(6)
Filter by category
Search
News
Statement zur Erweiterung der Europäischen Produktionskapazitäten und den daraus resultierenden Veränderungen des Auslieferungszeitplans
News
Statement on European Upscaling as well as Impact on Deliveries
News
Pfizer-BioNTech-COVID-19-Impfstoff induziert im Zellmodell Antikörper, die Pseudoviren mit dem Spike-Protein der U.K.-SARS-CoV-2-Variante neutralisieren
News
Pfizer and BioNTech Publish Results of Study Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture
News
Pfizer und BioNTech erzielen Vereinbarung mit COVAX für Vorabkauf von Impfstoff zur Bekämpfung von COVID-19
News
Pfizer and BioNTech Reach Agreement with COVAX for Advance Purchase of Vaccine to Help Combat COVID-19
News
BioNTech and Fosun Pharma Receive Authorization for Emergency Use in Hong Kong for COVID-19 Vaccine
News
Pfizer-BioNTech COVID-19-Impfstoff löst in vitro neutralisierende Antikörperantwort gegen SARS-CoV-2 mit Schlüsselmutationen der U.K.- und Südafrika-Varianten aus
News
In Vitro Studies Demonstrate Pfizer and BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with Key Mutations Present in U.K. and South African Variants
News
Pfizer und BioNTech veröffentlichen Zellmodell-Daten zu Neutralisierungspotential von COVID-19-Impfstoff-induzierten Antikörpern gegenüber U.K.-SARS-CoV-2-Varianten-Psdeudovirus in Science
Pagination
Previous page
‹‹
Page 2
Next page
››